Preddator Low-volume Microplate Dispenser Awarded ELRIG Prize
News Jul 10, 2013
Redd&Whyte has announced that its innovative Preddator low-volume microplate dispenser has been awarded the “ELRIG Technology Prize”, which recognizes the most interesting automation seen at the recent ELRIG Robotics and Automation Conference.
The award was voted for by delegates at the ELRIG Robotics and Automation show, in recognition of the fact that the Redd&Whyte Preddator nano dispenser has a unique design that is capable of precisely dispensing a wide range of fluid types and cell suspensions into any microplate format from 96-3456 wells.
The Preddator is an ideal research tool for a wide range of applications including: assay development, protein dispensing, DMSO backfilling, silicon oil deposition and PCR master mix preparation.
The system can be used as a stand-alone system or can be integrated into a range of different automated assay preparation and screening systems.
This award winning version of the Preddator is currently in operation at several of the top 10 pharma companies, where it is being successfully used in compound screening groups where consistency of assay data and reduction in assay costs are critical.
Roger Poole, Managing Director of Redd&Whyte said: “Redd&Whyte is honoured to be chosen for this prestigious ELRIG award. For the Preddator system to be acknowledged for liquid handling innovation alongside products from some of the world’s top automation firms is a great endorsement. This is a competition judged by ELRIG delegates and as such is very valuable recognition of the unique contribution Preddator can make to any compound screening workflow.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
BioAscent Announces New CEO and Plans to Expand Discovery Services OfferingNews
BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018